Home › Funds › BANK OF MONTREAL /CAN/ › AZN

BANK OF MONTREAL /CAN/ position in AZN

ASTRAZENECA PLC · Health Care

BANK OF MONTREAL /CAN/ reported holding 3,054,728 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$497.6M, representing 0.61% of its reported portfolio and ranking #28 among its reported holdings. BANK OF MONTREAL /CAN/ has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.05M sh
Reported value held$497.59M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BANK OF MONTREAL /CAN/'s AZN position evolved

BANK OF MONTREAL /CAN/ first disclosed a stake in AZN in Q3 2023 at 1,213,789 shares (US$83.4M). The position peaked in Q3 2026 at 3,054,728 shares, worth US$497.6M. Across 13 filings, BANK OF MONTREAL /CAN/ increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,054,728 shares valued at US$497.6M — an increase of 694,921 shares quarter over quarter.. Notable position changes include a 110% increase in Q3 2024 (shares fell 16% over the following quarter), a 118% increase in Q1 2025 (shares fell 5% over the following quarter), a 345% increase in Q3 2025 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.21M $83.40M New
Q4 2023 1.53M $103.07M Add
Q1 2024 1.08M $73.26M Reduce
Q2 2024 1.47M $116.92M Add
Q3 2024 3.07M $238.40M Add
Q4 2024 1.03M $67.24M Reduce
Q1 2025 2.24M $164.28M Add
Q2 2025 782.32K $54.67M Reduce
Q3 2025 3.48M $266.84M Add
Q4 2025 3.28M $301.32M Reduce
Q1 2026 1.93M $379.91M Reduce
Q2 2026 2.36M $441.24M Add
Q3 2026 3.05M $497.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 64 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has BANK OF MONTREAL /CAN/ held AZN?

BANK OF MONTREAL /CAN/ has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BANK OF MONTREAL /CAN/'s current position in AZN?

As of Q3 2026, BANK OF MONTREAL /CAN/ holds 3.05M shares of AZN (ASTRAZENECA PLC), valued at $497.59M, representing 0.61% of its reported portfolio and ranking #28.

Has BANK OF MONTREAL /CAN/ been buying or selling AZN?

In the latest 13F filing (Q3 2026), BANK OF MONTREAL /CAN/ increased its position in AZN. The position peaked in Q3 2026 at 3.05M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.